$TKNO Balance Sheet | Understand Stock

$TKNO

$6.59 +$0.17 (2.65%) Close

$TKNO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current assets:
Short-term investments - marketable securities
Cash and cash equivalents
Short-term investments, held -to-maturity
Accounts receivable, net of allowance for credit losses of $27 thousand and $23 thousand as of June 30, 2026 and December 31, 2025, respectively
Contract assets
Inventories, net
Income taxes receivable
Prepaid expenses and other current assets
Total current assets

Property, plant and equipment, net
Operating right-of-use lease assets
Goodwill
Intangible assets, net
Other non-current assets
Total assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
Accrued liabilities
Current portion of operating lease liabilities
Current portion of long-term debt
Total current liabilities
Deferred tax liabilities
Other accrued liabilities
Deferred rent
Long-term debt, net
Long-term operating lease liabilities
Total liabilities
Series A convertible and redeemable preferred stock, $0.00001 par value, zero and 9,600,000 shares authorized as of December 31, 2021 and December 31, 2020, respectively; zero and 9,342,092 shares issued and outstanding as of December 31, 2021 and December 31, 2020, respectively; aggregate liquidation preference of $0 and $41,586 thousand as of December 31, 2021 and December 31, 2020, respectively.
Stockholders’ equity:
Preferred stock, $0.00001 par value, 10,000,000 shares authorized at June 30, 2026 and December 31, 2025, respectively, zero shares issued and outstanding at June 30, 2026 and December 31, 2025
Common stock, $0.00001 par value, 490,000,000 shares authorized at June 30, 2026 and December 31, 2025, 53,682,647 and 53,562,154 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Total stockholders’ equity

Total liabilities and stockholders' equity

Comments